Consun Pharmaceutical Group Ltd

01681

Company Profile

  • Business description

    Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

  • Contact

    71, Dongpeng Avenue
    Eastern section
    Guangzhou Economic and Technological Development
    Guangzhou
    CHN

    T: +86 2082264529

    https://www.chinaconsun.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    3,164

Stocks News & Analysis

stocks

Strong result for ASX insurer but not the new norm

Stellar first half profits but increasing competition will lower future rate increases.
stocks

Eli Lilly earnings: Weak Orforglipron obesity data weighs down a strong quarter

With today’s share drop, we think Lilly stock looks fairly valued.
stocks

Solid 2025 for A-REIT but development activity will weigh on 2026

Positive news for income investors as yield exceeds 5%.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,117.6041.000.45%
CAC 407,725.9217.08-0.22%
DAX 4024,129.8233.04-0.14%
Dow JONES (US)44,175.61206.970.47%
FTSE 1009,126.5230.790.34%
HKSE24,906.8147.990.19%
NASDAQ21,450.02207.320.98%
Nikkei 22541,820.48761.331.85%
NZX 50 Index12,911.8667.230.52%
S&P 5006,389.4549.450.78%
S&P/ASX 2008,844.8037.700.43%
SSE Composite Index3,647.5512.420.34%

Market Movers